These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21199931)

  • 41. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
    Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
    Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
    Munir S; Mahmood N; Shahid S; Khan MI
    Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
    Liu Z; Shilkret KL; Finelli L
    Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I; Abe C; Mitarai S
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis.
    Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B
    Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates.
    Chen CJ; Yang YC; Huang HH; Chang TC; Lu PL
    Kaohsiung J Med Sci; 2019 Oct; 35(10):615-623. PubMed ID: 31433118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS; Woods GL
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.
    Elhassan MM; Hemeg HA; Elmekki MA; Turkistani KA; Abdul-Aziz AA
    Infect Disord Drug Targets; 2017; 17(1):14-23. PubMed ID: 27848902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
    Yamazaki T; Sato N; Yamashita K; Okazawa Y; Miyao H; Tanno K
    Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
    Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.
    Park WG; Bishai WR; Chaisson RE; Dorman SE
    J Clin Microbiol; 2002 Dec; 40(12):4750-2. PubMed ID: 12454186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
    Pagliotto AD; Caleffi-Ferracioli KR; Lopes MA; Baldin VP; Leite CQ; Pavan FR; Scodro RB; Siqueira VL; Cardoso RF
    J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Rao M; Sood R; Malhotra S; Fatma T; Upadhyay DJ; Rattan A
    J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.